|
May 27
|
Evolent Health, Amphastar Pharmaceuticals, Iridium, and Magnite Stocks Trade Up, What You Need To Know
|
|
May 23
|
Generic Pharmaceuticals Stocks Q1 In Review: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs Peers
|
|
May 22
|
Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
|
|
May 9
|
Amphastar Pharmaceuticals First Quarter 2025 Earnings: Misses Expectations
|
|
May 9
|
Amphastar Pharmaceuticals to Present at the 2025 Bank of America Health Care Conference
|
|
Apr 15
|
Is Amphastar Pharmaceuticals, Inc. (AMPH) the Best Pharma Stock to Buy for Long Term Growth?
|
|
Apr 15
|
2 Reasons to Like AMPH and 1 to Stay Skeptical
|
|
Mar 13
|
Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks
|
|
Mar 5
|
Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference
|
|
Mar 5
|
Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers
|
|
Feb 21
|
Q3 Earnings Outperformers: Viatris (NASDAQ:VTRS) And The Rest Of The Generic Pharmaceuticals Stocks
|
|
Feb 20
|
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 27, 2025
|
|
Feb 19
|
Generic Pharmaceuticals Stocks Q3 Teardown: Amneal (NASDAQ:AMRX) Vs The Rest
|
|
Nov 23
|
Amphastar initiated with an Equal Weight at Wells Fargo
|
|
Sep 19
|
Amphastar Pharmaceuticals (NASDAQ:AMPH) jumps 10% this week, though earnings growth is still tracking behind three-year shareholder returns
|
|
Aug 28
|
Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference
|
|
Aug 9
|
Amphastar Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
|
Aug 7
|
Compared to Estimates, Amphastar (AMPH) Q2 Earnings: A Look at Key Metrics
|
|
Aug 7
|
Amphastar Pharmaceuticals (AMPH) Tops Q2 Earnings and Revenue Estimates
|
|
Aug 7
|
Amphastar: Q2 Earnings Snapshot
|